These results suggest that VX765 can rescue the neuroinflammation caused by GPR120-AAV-KD in epilepsy, which further illustrated that GPR120-AAV-KD may cause neuroinflammation in epilepsy by promoting the expression of NLRP3 and thus activating Caspase-1. Here, FFAR4 is linked to epilepsy.